Multiple studies elucidated the importance of cellular immune mechanisms for protection against Mycobacterium tuberculosis. However, recent studies showed that B lymphocytes play a role that is underestimated through various interactions with cellular immune response, forming an important aspect of host defense against M. tuberculosis bacteria. Therefore, the author hereby proposes a progressive perspective for immunology of tuberculosis, i.e., cellular immunity and humoral immunity are not necessarily mutually exclusive. The present study summarizes recent studies that support the important role of B lymphocytes in terms of M. tuberculosis infection.
Mycobacterium tuberculosis (Mtb) belong to Mycobacterium genus. This pathogenic species causes tuberculosis (TB). TB remains an important infectious disease nowadays. This disease can invade body organs, with pulmonary TB being the most commonly observed. Humoral immunity plays a negligible role in the defense against Mtb. However, antibodies were reported to pose effects on Mtb since the late 19th century. Humoral immunity indicates that under stimulations from antigens, as represented by B lymphocytes, i m mu noc y te s i n t he i m mu ne s y s tem of orga n i sm s differentiate and proliferate into plasma cells and synthesize various types of antibodies to generate specific immune responses with biological effects. Adoptively transferred B lymphocytes can limit deterioration of inf lammations induced by TB [1] . This condition demonstrates the important role of immunoglobulin-mediated immune regulation. The present study summarizes recent studies on humoral immunity against Mtb.
Relevant antigens of humoral immunity against Mtb
Antigen 85 complex A ntigen 85 complex (Ag85) comprises at least three components, namely, 85A, 85B, and 85C. Up to 70%-80% of sequences of these components are the same. As a fibronectin-binding protein, Ag85 exists in higher amounts of serum of patients with active TB in comparison with patients with non-active TB or other lung diseases or healthy controls [2] . In the study among indigenous people of Mexico, Abebe et al. [3] proved that IgG exhibits good effect on Mtb complex Ag85. Another study showed that compared with patients cured by anti-TB treatment, effective antibody titer was more remarkable for Ag85 in non-cavernous TB. Antigen 85B (Ag85B) is one of the important immunoprotective antigens against Mtb infection, and it is widely used in studies on new vaccines for TB. Studies showed that when immunizing mice/guinea pig, effective immune response is induced by both plasmids encoding Mtb single Ag85B and plasmid expressed by multigene fusion of Ag85B and other protective antigens against Mtb. Thus, the number of bacteria in visceral organs, such as the lungs and spleen, significantly reduces, and survival time of experimental animals extends. Studies also showed that DNA vaccine encoding Ag85B exhibits good immunotherapy effects. Both Ag85B and early secretory antigenic target-6 (ESAT-6) in Mtb culture filtrate protein can stimulate organisms to generate protective immune responses. These antigens are also effective target for anti-TB infection of organisms. Ag85B and ESAT-6 can induce certain levels of cellular immune response, humoral immune response, and certain degree of immune protection force, thus providing defense against Mtb infection.
Protein with a relative molecular mass of 38×10 3 The protein is a membrane lipoid protein of M. tuberculosis and a specific protein of M. tuberculosis complex group. This molecule also exists in bacillus Calmette-Guerin (BCG) vaccine, with expression quantity 10 times higher than that of BCG [3] . The antigen contains seven antigenic epitopes and can induce humoral and cellular immune responses and be used for serological diagnosis of TB.
Lipoarabinomanna (LAM)
LAM is a Mtb-glycosylated lipoid protein and a membrane protein of Mtb. LAM contains seven monoclonal antibodybinding epitopes, features immune advantages for B lymphocytes, and can induce early immune response. Related experiments showed that specificity and sensitivity of L A M i n i m mu nolog ic d iag nosis of pat ients w it h pulmonary TB reached 78.3% and 50.5%, respectively [4] .
Heat shock protein
Heat shock protein is a heat stress protein that ex ists extensively from bacteria to mammals. When exposed to high temperatures, thermal excitation induces synthesis of such protein to protect organisms and to stimulate responses from T and B lymphocytes. As a somatic protein, heat shock protein exhibits regulatory functions and protective effects on cells, and high homology is observed between the same kinds of protein in prokaryotic and eukaryotic cells. In heat shock protein family, one Mtb and BCG-specific epitope exists, exhibiting good immune protection and immunotherapy effects [5] .
Surface molecules and subgroups related to B lymphocytes and TB humoral immune response [7] reported that the most prominent change in peripheral blood of TB patients is the significantly increased ratio of CD19+ CD5+CD1d+ B lymphocy te subgroup. The B lymphocy te subgroup is considered a group of B lymphocytes with regulating f unction. This group can inhibit CD4+ T cells from secreting IL-17, indicating that these cells exhibit certain i mmunosuppressive f unction. CD19+CD5-CD1d+B, CD19+CD5-CD1d-B, and CD19+CD5+CD1d-B cells do not inhibit IL-17, and their specific functions remain unclear. Corominas et al. [8] discovered through their study that CD86 expressed by B cell surface can regulate immune response to Mtb infection. As antigen presenting cells, B lymphocytes can induce generation of certain cytokines that favor Th2 response. This phenomenon indicates that B7 (CD80/CD86) expression plays an important role in anti-TB function of T lymphocytes.
Antigen presentation of TB humoral immune response
Maglione et al. [1] observed that B lymphocytes display different f unctions at various stages of TB infection. In acute infectious stage, B lymphocytes participate in granuloma response and effectively inhibit pulmonary TB infections. Deletion of B lymphocytes leads to aggravated inflammations and granulomatous dysregulation. In chronic stage of Mtb infection, activated subgroups of B lymphocytes may exhibit immune effects on Mtb of primary lesions and thus prevent disease relapse. Such role is partially fulfilled by B lymphocytes as antigen-presenting cells. Although antigen uptake is performed by BCR in a specific manner, B lymphocytes can absorb receptor-specific peptides that fail to conform to major histocompatibility complex. Zhang et al. [9] proposed that granulomas are highly germinal centers for B lymphocytes, and B lymphocytes effectively present antigens and simulate activation of immune cells in lesions.
Antibodies of TB humoral immune response and their functions
I n v it ro st ud ies on mecha n ism of hu mora l i m mu ne protection of organisms [10] showed that specific antibodies can inhibit replication of pathogenic bacteria, neutralize toxins secreted by pathogens, enhance antibody-dependent cell-mediated cytotoxicity (ADCC), play the role of opsonin, and induce a series of complement reactions. Antibodies in the body can enhance endocytosis for Mtb and lethal effects of neutrophil granulocytes and macrophages. Mtb coated with specific antibodies can stimulate responses from CD4 and CD8, thereby enabling their effective processing and presentation. Serological test for diagnosis of TB became a research topic because of study results indicating enhanced humoral immunity of TB patients but weakened cellular immunity. Julian et al. [11] developed serological diagnosis methods, including detection of Ig60 antibody, Kp90ImCR AC (mycobacterial immunocross reactive), and LAM antibodies, showing sensibility of 20% -93% and specif icit y of 62% -10 0%. Recently, Reis et al. [12] proposed that antibodies may display the following functions in infection sites. As for Mtb coated with antibodies (extracellular) with FcγR in immune response, after Fc receptor combines with immune complex, it intracellularly transmits activation signals through γ-chain immunoreceptor tyrosine-based activation motif. Fc receptor also mediates multiple immune responses, such as cell activation, ADCC, generation of super-oxygen ion, antigen presentation, phagocytosis, and pinocytosis, playing an important role in elimination of immune complexes and regulation of immune functions of organisms. Reljic et al. [13] discovered from mouse model infected with TB that anti-Mtb monoclonal antibodies, including LA M, 16 ku crystalline, and heparin-binding hemagglutinin adhesion, all function effectively in TB treatment. These antibodies indirectly protect organisms in various ways: some reduce Mtb microbial load in tissues, and some delay progression of inflammations and prolong survival time of animals.
After diagnosis with TB, organisms first respond by increasing anti-TB IgM, followed by continuous increase of IgG. Periods of presentation of humoral immunity and anti-TB IgM and IgG also differ because of different courses of TB. Detection of TB antibody IgM is an important reference for early TB diagnosis. Saunders et al. [14] showed in a study on macaque that B lymphocytes mainly gather in granulomas and express CXCR5 and human leukocyte antigen-D related. Phuah et al. [15] observed that compared with non-infected tissues, tissues containing Mtb can generate higher levels of specific IgG, and Mtb granuloma-specific antibodies can be detected in plasma cells. All the above findings indicated that B lymphocytes exist in certain Mtb pathogen infection sites (pulmonary granuloma and chest lymph nodes) and can accordingly produce antibodies that control local infections. Jasmer et al. [16] reported that in patients infected with TB combined human immunodeficiency virus (HIV), IgG levels of anti-PPD antibodies vary because of different stages of HIV infection. This phenomenon may be caused by phosphorylation of defective T cell receptors, inducing deletion and activation of zeta-chain-associated protein kinase 70 and IL-2 gene transcription-related mitogenactivated protein kinase protein and protein mass deficiency after T lymphocyte stimulation by antigens. Decreases in γδT cells result in decreased generation of interferon (IFN)-γ and increased content of IL-10, which is responsive to PPD, whereas antituberculin isotype IgG3 antibody can prevent TB reactivation [17] . Recently, Balu et al. [18] revealed that after inoculating human anti-Mtb α-crystal protein IgA antibody into nasal cavity of CD89 transgenic mice, infection of H37Rv M. tuberculosis strain reduced.
Immune regulation of B lymphocytes in TB infection
In addition to ser ving as antigen-presenting cells and produci ng a nt ibod ies, B ly mphoc y tes ca n st i mu late proliferation, growth, and differentiation of T lymphocytes. Activated B lymphocytes can generate different cytokines. Secretion of cytokines (e.g., IFN-γ and IL-12) in certain ef fector B (B -1) cel ls is related to T h1. Activated B lymphocytes can secrete large amounts of IL-6 and IL-10, playing an auxiliary role in immunity of T lymphocytes. IL-6 is a vital factor that synergistically stimulates responses of T lymphocytes. By contrast, IL-10 inhibits immune response of T lymphocytes. IL-10 can strongly inhibit dendritic cells and macrophages and also prevent generation of IL-6 and IL-12 through these cells [19] .
Conclusion
TB is a serious and globally spreading infectious disease. However, to date, studies provide inadequate information regarding TB and TB pathogens and fail to elucidate mechanism of anti-TB infection of hosts. Sustained and long-term efforts should be applied to control and eradicate TB. Continuous development of molecular biology and immunology laid theoretical and practical foundations for studies on related substances and mechanisms of humoral immune in TB infection. We believe that breakthroughs can be achieved by future research in this field.
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